Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.900
-0.020 (-1.04%)
At close: Jul 2, 2026, 4:00 PM EDT
1.900
0.00 (0.00%)
After-hours: Jul 2, 2026, 8:00 PM EDT
Serina Therapeutics Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered eight proposals, all of which were approved, including director elections, share increase, incentive plan amendment, and auditor ratification. No questions were raised by stockholders, and final voting results will be filed with the SEC.
-
The POZ platform enables improved delivery of small molecules, with lead program SER-252 in advanced Parkinson's showing promise for best-in-class therapy and a $1.7–$2.5 billion market opportunity. Additional programs target tardive dyskinesia and an undisclosed CNS indication, with a focus on accelerated regulatory pathways and potential partnerships.